Invenomic Capital Management LP Purchases 46,535 Shares of Universal Health Services, Inc. $UHS

Invenomic Capital Management LP boosted its position in shares of Universal Health Services, Inc. (NYSE:UHS) by 174.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,266 shares of the health services provider’s stock after acquiring an additional 46,535 shares during the period. Invenomic Capital Management LP owned 0.12% of Universal Health Services worth $14,979,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of UHS. Allspring Global Investments Holdings LLC raised its position in shares of Universal Health Services by 34.9% in the third quarter. Allspring Global Investments Holdings LLC now owns 68,501 shares of the health services provider’s stock worth $13,941,000 after buying an additional 17,728 shares in the last quarter. American Century Companies Inc. grew its position in Universal Health Services by 22.1% during the third quarter. American Century Companies Inc. now owns 781,145 shares of the health services provider’s stock worth $159,698,000 after buying an additional 141,621 shares in the last quarter. Rakuten Investment Management Inc. purchased a new position in Universal Health Services during the third quarter worth about $1,359,000. First Citizens Bank & Trust Co. increased its stake in Universal Health Services by 36.0% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 54,960 shares of the health services provider’s stock worth $11,236,000 after acquiring an additional 14,536 shares during the last quarter. Finally, AMG National Trust Bank bought a new position in Universal Health Services in the 3rd quarter worth about $1,912,000. 86.05% of the stock is currently owned by hedge funds and other institutional investors.

Universal Health Services Stock Performance

NYSE:UHS opened at $192.45 on Monday. The firm has a market cap of $11.76 billion, a PE ratio of 8.31, a price-to-earnings-growth ratio of 0.76 and a beta of 1.26. Universal Health Services, Inc. has a fifty-two week low of $152.33 and a fifty-two week high of $246.32. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.98 and a current ratio of 1.05. The business has a 50 day moving average price of $210.01 and a 200-day moving average price of $212.06.

Universal Health Services (NYSE:UHS) last issued its earnings results on Wednesday, February 25th. The health services provider reported $5.88 EPS for the quarter, missing the consensus estimate of $5.92 by ($0.04). Universal Health Services had a return on equity of 19.65% and a net margin of 8.57%.The firm had revenue of $4.49 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same period in the previous year, the firm earned $4.92 earnings per share. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. Equities research analysts predict that Universal Health Services, Inc. will post 15.92 earnings per share for the current year.

Universal Health Services Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. Universal Health Services’s dividend payout ratio is currently 3.46%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on UHS. Wall Street Zen downgraded Universal Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 28th. Weiss Ratings reissued a “buy (b)” rating on shares of Universal Health Services in a research note on Monday, December 29th. Guggenheim increased their price target on shares of Universal Health Services from $253.00 to $274.00 and gave the stock a “buy” rating in a report on Tuesday, December 2nd. UBS Group restated a “buy” rating on shares of Universal Health Services in a research report on Thursday, January 15th. Finally, TD Cowen dropped their price objective on shares of Universal Health Services from $251.00 to $245.00 and set a “buy” rating for the company in a report on Wednesday, January 7th. Six research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Universal Health Services presently has an average rating of “Hold” and an average price target of $232.21.

Universal Health Services Company Profile

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.